128 results
Page 3 of 7
6-K
EX-99.1
yij2m4 n9
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
thyby33x 4zxvs7e
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.6
h0tbznf389aokwv48lb
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
c82q0yg0
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.2
e4k4ib36u3ty6pd9
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
dbfql8 0i
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
46kdw0jq6ymbrtk441
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
4m8uvt a7uwfsjpqisqc
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
so11nu zi1go6d20
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
4pbl1xoacj6taba
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
hnc03 zi03jied297
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
wtofi9f
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
g6fpgxb70ekd1df6nw
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
pljgb8kl7y
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.1
e5kql5dg1wvqrac cif
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
bgoeh9 f7lpjy9
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
b6h1l wv1x
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm